China Proposes Stricter Rules And Higher Penalties For Recalls
Executive Summary
The China Food and Drug Administration wants to expand the scope of products subject to recall and increase the penalties for wrongdoers.
You may also be interested in...
China To Get Tougher On Recalls Beginning In May
More stringent recall rules in China will see the maximum penalty for failure to carry out a mandatory recall rise from three times the value of a medical device, to up to ten times its value.
China Clinical Data Crackdown Sees Device-Makers Withdraw 101 Applications
China FDA is now relentlessly clamping down on clinical data irregularities in the medtech industry, causing 51 manufacturers, including well-known multinational companies such as Boston Scientific and Olympus, to withdraw more than a hundred new device approvals filed with the agency.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.